CLINICAL MODULATION OF DOXORUBICIN RESISTANCE BY THE CALMODULIN-INHIBITOR, TRIFLUOPERAZINE - A PHASE-I/II TRIAL

被引:144
作者
MILLER, RL
BUKOWSKI, RM
BUDD, GT
PURVIS, J
WEICK, JK
SHEPARD, K
MIDHA, KK
GANAPATHI, R
机构
[1] CLEVELAND CLIN EDUC FDN,DEPT HEMATOL ONCOL,9500 EUCLID AVE,CLEVELAND,OH 44106
[2] CLEVELAND CLIN EDUC FDN,DEPT CANC & IMMUNOL,CLEVELAND,OH 44106
[3] NCI,BRMP,FREDERICK,MD 21701
[4] UNIV SASKATCHEWAN,COLL PHARM,SASKATOON S7N 0W0,SASKATCHEWAN,CANADA
[5] UNIV SASKATCHEWAN,COLL MED,SASKATOON S7N 0W0,SASKATCHEWAN,CANADA
[6] BURROUGHS WELLCOME CO,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1200/JCO.1988.6.5.880
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:880 / 888
页数:9
相关论文
共 31 条
[1]  
BACHUR NR, 1977, CLIN PHARMACOL THER, V21, P70
[2]  
Baldessarini R. J., 1980, PHARMACOL BASIS THER, P391
[3]  
CHABNER BA, 1986, J CLIN ONCOL, V4, P625
[4]  
CURT GA, 1984, CANCER TREAT REP, V68, P87
[5]   ACTIVE OUTWARD TRANSPORT OF DAUNOMYCIN IN RESISTANT EHRLICH ASCITES TUMOR-CELLS [J].
DANO, K .
BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 323 (03) :466-483
[6]   TUMOR HETEROGENEITY AND DRUG-RESISTANCE [J].
DEXTER, DL ;
LEITH, JT .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (02) :244-257
[7]   CORRELATION BETWEEN POTENCY OF CALMODULIN INHIBITORS AND EFFECTS ON CELLULAR-LEVELS AND CYTO-TOXIC ACTIVITY OF DOXORUBICIN (ADRIAMYCIN) IN RESISTANT P388 MOUSE LEUKEMIA-CELLS [J].
GANAPATHI, R ;
GRABOWSKI, D ;
TURINIC, R ;
VALENZUELA, R .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (06) :799-806
[8]  
GANAPATHI R, 1983, CANCER RES, V43, P3696
[10]  
GANAPATHI R, 1984, CANCER RES, V44, P5056